12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population

Ryo Takata, Hidewaki Nakagawa(RIKEN Center for Integrative Medical Sciences), Hiroki Yamada(Keio University), Masashi Fujita(Institute of Neuroimmunology of the Slovak Academy of Sciences), Kazuhiro Maejima(RIKEN Center for Integrative Medical Sciences), Johji Inazawa(Shanghai Institute for Science of Science), Yuichiro Nishida(Saga University), Kenji Wakai(Japanese Society for Dialysis Therapy), Motoki Iwasaki, Naoko Minegishi(Tohoku Medical Megabank Organization), Atsushi Shimizu(Keio University), Yoichiro Kamatani(RIKEN Center for Integrative Medical Sciences), Kichiya Suzuki(Tohoku University), Wataru Obara(Iwate Medical University), Shoichiro Tsugane(International University of Health and Welfare), Taiki Yamaji, Christopher A. Haiman(University of Southern California), Keitaro Matsuo(Aichi Cancer Center), Edward J. Saunders(Institute of Cancer Research), Kozo Tanno(Iwate Medical University), Norie Sawada(National Cancer Center), Koichi Matsuda(The University of Tokyo), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Kaoru Nakano(RIKEN Center for Integrative Medical Sciences), Shusuke Akamatsu(Kyoto University), Asahi Hishida(Nagoya City University), Osamu Ogawa(Kyoto University Hospital), Makoto Sasaki(Iwate Medical University), Atsushi Takahashi(Fukushima Medical University), Shin Egawa, Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences)
Nature Communications
September 27, 2019
Cited by 62


Related Papers